161 related articles for article (PubMed ID: 36777735)
1. Arachidonate lipoxygenases 5 is a novel prognostic biomarker and correlates with high tumor immune infiltration in low-grade glioma.
Pan RH; Zhang X; Chen ZP; Liu YJ
Front Genet; 2023; 14():1027690. PubMed ID: 36777735
[No Abstract] [Full Text] [Related]
2. Abundant expression of ferroptosis-related SAT1 is related to unfavorable outcome and immune cell infiltration in low-grade glioma.
Mou Y; Zhang L; Liu Z; Song X
BMC Cancer; 2022 Feb; 22(1):215. PubMed ID: 35227235
[TBL] [Abstract][Full Text] [Related]
3. Next-generation sequencing identifies HOXA6 as a novel oncogenic gene in low grade glioma.
Xiulin J; Wang C; Guo J; Wang C; Pan C; Nie Z
Aging (Albany NY); 2022 Mar; 14(6):2819-2854. PubMed ID: 35349479
[TBL] [Abstract][Full Text] [Related]
4. Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma.
Lu J; Peng Y; Huang R; Feng Z; Fan Y; Wang H; Zeng Z; Ji Y; Wang Y; Wang Z
BMC Cancer; 2021 Jun; 21(1):723. PubMed ID: 34162355
[TBL] [Abstract][Full Text] [Related]
5. EFNA1 is a potential key gene that correlates with immune infiltration in low-grade glioma.
Hao YP; Wang WY; Qiao Q; Li G
Medicine (Baltimore); 2021 Jun; 100(22):e26188. PubMed ID: 34087884
[TBL] [Abstract][Full Text] [Related]
6. PTPRN Serves as a Prognostic Biomarker and Correlated with Immune Infiltrates in Low Grade Glioma.
Li P; Chen F; Yao C; Zhu K; Zhang B; Zheng Z
Brain Sci; 2022 Jun; 12(6):. PubMed ID: 35741647
[TBL] [Abstract][Full Text] [Related]
7. DNA methylation-regulated SNX20 overexpression correlates with poor prognosis, immune cell infiltration, and low-grade glioma progression.
Chen X; Jiang X; Wang H; Wang C; Wang C; Pan C; Zhou F; Tian J; Niu X; Nie Z; Chen W; Huang X; Pu J; Li C
Aging (Albany NY); 2022 Jun; 14(12):5211-5222. PubMed ID: 35771139
[TBL] [Abstract][Full Text] [Related]
8. DNA methylation-regulated YTHDF2 correlates with cell migration and immune cell infiltration in glioma.
Jiang X; Chen X; Huang X; Wang C; Wang C; Pan C; Cho WC; Nie Z; Pu J; Wang W
Aging (Albany NY); 2022 Jun; 14(19):7774-7793. PubMed ID: 35661004
[TBL] [Abstract][Full Text] [Related]
9. Elevated RECQL1 expression predicts poor prognosis and associates with tumor immune infiltration in low-grade glioma.
Wang G; Cen Y; Wang C; Xiang W; Li S; Ming Y; Chen L; Zhou J
Transl Cancer Res; 2022 Jun; 11(6):1552-1564. PubMed ID: 35836526
[TBL] [Abstract][Full Text] [Related]
10. Correlation between ITGB2 expression and clinical characterization of glioma and the prognostic significance of its methylation in low-grade glioma(LGG).
Liu H; Wang J; Luo T; Zhen Z; Liu L; Zheng Y; Zhang C; Hu X
Front Endocrinol (Lausanne); 2022; 13():1106120. PubMed ID: 36714574
[TBL] [Abstract][Full Text] [Related]
11. High expression of ZFP36L2 correlates with the prognosis and immune infiltration in lower-grade glioma.
Zhou M; Li J; Chen C
Front Genet; 2022; 13():914219. PubMed ID: 35910229
[No Abstract] [Full Text] [Related]
12. Prognostic significance of ARL9 and its methylation in low-grade glioma.
Tan Y; Zhang S; Xiao Q; Wang J; Zhao K; Liu W; Huang K; Tian W; Niu H; Lei T; Shu K
Genomics; 2020 Nov; 112(6):4808-4816. PubMed ID: 32882327
[TBL] [Abstract][Full Text] [Related]
13. Identification and validation of RNA methylation-related alternative splicing gene signature for low-grade glioma to predict survival and immune landscapes.
Ma C; Bao Y; Xu J; Xiao B; Li H
J Cancer Res Clin Oncol; 2023 Jan; 149(1):47-62. PubMed ID: 36528831
[TBL] [Abstract][Full Text] [Related]
14. MCM4 is a novel prognostic biomarker and promotes cancer cell growth in glioma.
Yang S; Yuan Y; Ren W; Wang H; Zhao Z; Zhao H; Zhao Q; Chen X; Jiang X; Zhang L
Front Oncol; 2022; 12():1004324. PubMed ID: 36465369
[TBL] [Abstract][Full Text] [Related]
15. The N6-Methylandenosine-Related Gene
Jiang X; Shi Y; Chen X; Xu H; Huang X; Li L; Pu J
Front Mol Biosci; 2022; 9():773662. PubMed ID: 35309512
[TBL] [Abstract][Full Text] [Related]
16.
Jiang W; Zheng F; Yao T; Gong F; Zheng W; Yao N
Ann Transl Med; 2021 Nov; 9(22):1686. PubMed ID: 34988195
[TBL] [Abstract][Full Text] [Related]
17. NCAPG2 Is a Novel Prognostic Biomarker and Promotes Cancer Stem Cell Maintenance in Low-Grade Glioma.
Ren W; Yang S; Chen X; Guo J; Zhao H; Yang R; Nie Z; Ding L; Zhang L
Front Oncol; 2022; 12():918606. PubMed ID: 35898895
[TBL] [Abstract][Full Text] [Related]
18. PCGF1 is a prognostic biomarker and correlates with tumor immunity in gliomas.
Xie J; Qiao L; Deng G; Liang N; Xing L; Zhang J
Ann Transl Med; 2022 Feb; 10(4):227. PubMed ID: 35280367
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive Prognostic Analysis of Immune Implication Value and Oxidative Stress Significance of NECAP2 in Low-Grade Glioma.
Lu Z; Chen Y; Chen S; Zhu X; Wang C; Wang Z; Yao Q
Oxid Med Cell Longev; 2022; 2022():1494520. PubMed ID: 36531205
[TBL] [Abstract][Full Text] [Related]
20. Expression, methylation and prognostic feature of EMILIN2 in Low-Grade-Glioma.
Wang LC; Cui WY; Zhang Z; Tan ZL; Lv QL; Chen SH; Shen XL
Brain Res Bull; 2021 Oct; 175():26-36. PubMed ID: 34280481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
